Japan Lifeline Co., Ltd. Revises Consolidated and Non-Consolidated Earnings Guidance for the Fiscal Year Ending 31, 2024
November 06, 2023 at 01:10 am EST
Share
Japan Lifeline Co., Ltd. revised consolidated and non-consolidated earnings guidance for the fiscal year ending 31, 2024. For the period, consolidated basis, the company expected net sales of JPY 50,680 million, operating profit of JPY 10,945 million, net profit attributable to owners of parent of JPY 7,902 million and net profit per share of JPY 103.81 compared to previously expected net sales of JPY 48,807 million, operating profit of JPY 9,763 million, net profit attributable to owners of parent of JPY 6,854 million and net profit per share of JPY 89.13.
For the period, non-consolidated basis, the company expected net sales of JPY 50,680 million, operating profit of JPY 10,890 million, net profit attributable to owners of parent of JPY 7,640 million and net profit per share of JPY 100.38 compared to previously expected net sales of JPY 48,807 million, operating profit of JPY 9,807 million, net profit attributable to owners of parent of JPY 6,894 million and net profit per share of JPY 89.66.
Japan Lifeline Co., Ltd. is a Japan-based company mainly engaged in the import, manufacture and sale of cardiac circulators and other medical devices. The Company is mainly engaged in the production of rhythm devices, electrophysiological (EP) and ablations, surgical products and intervention products. The rhythm devices include cardiac pacemakers, implantable cardioverter defibrillator (ICD), cardiac resynchronization therapy defibrillator (CRT-D) and other rhythm devices. The EP and ablations include EP catheters for cardiac arrhythmia examination, ablation catheters for arrhythmia treatment and other EP and ablations. The surgical products include prosthetic heart valves and annuloplasty rings for heart disease surgical treatment, vascular grafts, open stent grafts and stent grafts for aortic disease treatment, as well as other surgical products. The intervention products include balloon catheters, guide wires, penetration catheters and other intervention products.